Literature DB >> 9587415

Expression of pyruvate dehydrogenase isoforms during the aerobic/anaerobic transition in the development of the parasitic nematode Ascaris suum: altered stoichiometry of phosphorylation/inactivation.

Y J Huang1, D Walker, W Chen, M Klingbeil, R Komuniecki.   

Abstract

The pyruvate dehydrogenase complex (PDC) plays a key role in the anaerobic metabolism of the parasitic nematode Ascaris suum. Two isoforms of the alpha-subunit of pyruvate dehydrogenase (E1) have been identified: alpha I is most abundant in anaerobic adult muscle and alpha II in aerobic larvae. Both isoforms have been expressed as alpha 2 beta 2 tetramers with a muscle-specific beta-subunit, purified to apparent homogeneity, reconstituted with E1-deficient adult A. suum muscle PDC, and assayed for PDC and E1 kinase activity. Recombinant alpha II is a poor substrate for the adult E1 kinase, but its stoichiometry of phosphorylation/inactivation is similar to that reported for the human E1. Initially, inactivation parallels the incorporation of about 1 mol 32P/mol E1 and at maximal phosphorylation about 2.4 32P/mol E1 is incorporated. In contrast, recombinant alpha I (r alpha I) is phosphorylated rapidly, and substantially more phosphorylation accompanies inactivation. To examine this altered pattern of phosphorylation, the two phosphorylation sites in each E1 alpha subunit of the r alpha I (site 1 and site 2) were changed either individually or together from Ser to Ala by site-directed mutagenesis. Site 1 was phosphorylated more rapidly than site 2, but the phosphorylation of either site resulted in inactivation, and the phosphorylation of only a single E1 alpha subunit of the tetramer was necessary for inactivation. However, both E1 alpha subunits of the tetramer were phosphorylated, based on the incorporation of about 3.5 mol 32P/mol E1 at maximal phosphorylation and the altered mobility of most of the E1 alpha subunits during SDS-PAGE. These observations suggest that the regulation of both E1 isoforms is modified to maintain PDC activity during the transition to anaerobiosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9587415     DOI: 10.1006/abbi.1998.0596

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  6 in total

1.  Effect of silymarin on gluconeogenesis and lactate production in exercising rats.

Authors:  Eun-Ju Choi; Eun-Kyung Kim; Nam Ho Jeoung; Sang-Hyun Kim
Journal:  Food Sci Biotechnol       Date:  2016-03-31       Impact factor: 2.391

2.  Nematode pyruvate dehydrogenase kinases: role of the C-terminus in binding to the dihydrolipoyl transacetylase core of the pyruvate dehydrogenase complex.

Authors:  W Chen; P R Komuniecki; R Komuniecki
Journal:  Biochem J       Date:  1999-04-01       Impact factor: 3.857

3.  Tandem Mass Tagging (TMT) Reveals Tissue-Specific Proteome of L4 Larvae of Anisakis simplex s. s.: Enzymes of Energy and/or Carbohydrate Metabolism as Potential Drug Targets in Anisakiasis.

Authors:  Robert Stryiński; Jesús Mateos; Mónica Carrera; Jan Paweł Jastrzębski; Iwona Bogacka; Elżbieta Łopieńska-Biernat
Journal:  Int J Mol Sci       Date:  2022-04-14       Impact factor: 6.208

4.  The proteome expression patterns in adult Ascaris suum under exposure to aerobic/anaerobic environments analyzed by two-dimensional electrophoresis.

Authors:  M Khyrul Islam; Takeharu Miyoshi; Yuichi Yokomizo; Naotoshi Tsuji
Journal:  Parasitol Res       Date:  2004-04-28       Impact factor: 2.289

Review 5.  The Central Role of Biometals Maintains Oxidative Balance in the Context of Metabolic and Neurodegenerative Disorders.

Authors:  Michal Pokusa; Alžbeta Kráľová Trančíková
Journal:  Oxid Med Cell Longev       Date:  2017-07-02       Impact factor: 6.543

6.  Proteomic analysis of Oesophagostomum dentatum (Nematoda) during larval transition, and the effects of hydrolase inhibitors on development.

Authors:  Martina Ondrovics; Katja Silbermayr; Makedonka Mitreva; Neil D Young; Ebrahim Razzazi-Fazeli; Robin B Gasser; Anja Joachim
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.